Omitting RT After Lumpectomy Yields 14.8% 5-Year Local Recurrence in Older Women
CancerNetwork26 Oct · 23:28← Topics · 26 Oct
Development ↘
Development ↘
Development ↘
Development ↘
Development ↘
Development ↘
As it stood that day
New studies are examining GLP-1 drugs and tamoxifen’s effects in breast cancer care.
7 reports · 26 Oct
Summary · from headlines1 point
- TOP-1 study reports 14.8% five-year local recurrence after radiotherapy omission in older women with breast cancer.
Latest developments6 to read first
Low-Dose Tamoxifen Changes Breast Cancer Risk Biomarkers in High-Risk Women
Medscape26 Oct · 20:28Exploring The Use of GLP-1 Receptor Agonists in Breast Cancer Care
CancerNetwork26 Oct · 20:18Most advanced breast cancer patients treated in community settings, Phesi study finds
Pharmafile26 Oct · 18:48HER2-Positive Breast Cancer in Algeria: What Happens After Neoadjuvant Therapy?
Oncodaily26 Oct · 04:38weight loss drugs linked to cancer
BusinessWorld Online26 Oct · 01:38Timeline 7 reports
26 Oct 20267 reports
23:001 report
22:00nothing heard
21:00nothing heard
20:002 reports
19:00nothing heard
18:001 report
17:00nothing heard
16:00nothing heard
15:00nothing heard
14:00nothing heard
13:00nothing heard
12:00nothing heard
11:00nothing heard
10:00nothing heard
09:00nothing heard
08:00nothing heard
07:00nothing heard
06:00nothing heard
05:00nothing heard
04:001 report
03:00nothing heard
02:00nothing heard
01:001 report
00:001 report
← Topics · 26 OctOne topic